Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Identify the Aristocrats ETF with the lowest fee and understand how that impacts long-term returns, including potential trade-offs.
20,652 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
The U.S. government has expanded direct stakes in select public firms, tying national security goals to market moves ...
Investors are weighing whether lululemon stocks stage turnaround is still on the table. This guide breaks down the fa...
Pred secures a $2.5 million funding round led by ACCEL, aiming to deliver the fastest on-chain sports prediction trad...
As markets swing on inflation relief and rate expectations, a well-known consumer staples leader sits at a bargain, o...
Cracking the code on a potential real estate rebound? play means stacking three strategic bets: affordable debt, grow...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
Citigroup names Jenn Landis as CFO of its Markets unit, highlighting a broader leadership reshuffle aimed at aligning...
For years, Annaly stock drew steady income seekers. Today, a different financial stock could outperform on yield and ...
Strategy shareholders approved a plan to start semi-monthly dividends on STRC preferred stock, aiming to steady price...
A Michigan-based class-action accuses Veterans United Home Loans of misleading branding tied to VA affiliation, alleg...